Wird geladen...

Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone

Ritonavir is a potent inhibitor of the cytochrome P450 enzyme CYP3A4 and is subject to multiple drug–drug interactions. This becomes especially important when the patient is also taking medications metabolized through CYP3A pathway as increased and potentially toxic drug levels may ensue. Herein we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Springerplus
Hauptverfasser: Epperla, Narendranath, McKiernan, Fergus
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4549367/
https://ncbi.nlm.nih.gov/pubmed/26322261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-015-1218-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!